DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 118 filers reported holding DYNE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663,470 | +78.7% | 74,048 | +124.3% | 0.00% | – |
| Q2 2023 | $371,329 | -36.2% | 33,007 | -34.7% | 0.00% | – |
| Q1 2023 | $581,910 | +194.9% | 50,513 | +196.7% | 0.00% | – |
| Q4 2022 | $197,308 | -41.6% | 17,024 | -36.1% | 0.00% | – |
| Q3 2022 | $338,000 | +48.2% | 26,651 | +81.5% | 0.00% | – |
| Q1 2021 | $228,000 | – | 14,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |